Safety & PK of Single Doses of MT1980

NCT05429840 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuroinflammatory Response

Interventions

DRUG: MT1980
DRUG: Placebo

Sponsor

Monument Therapeutics Limited

Collaborators

[object Object]